BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

941 related articles for article (PubMed ID: 29248131)

  • 1. Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development.
    Wilde L; Roche M; Domingo-Vidal M; Tanson K; Philp N; Curry J; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):198-203. PubMed ID: 29248131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.
    Curry JM; Tuluc M; Whitaker-Menezes D; Ames JA; Anantharaman A; Butera A; Leiby B; Cognetti DM; Sotgia F; Lisanti MP; Martinez-Outschoorn UE
    Cell Cycle; 2013 May; 12(9):1371-84. PubMed ID: 23574725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma.
    Duan K; Liu ZJ; Hu SQ; Huo HY; Xu ZR; Ruan JF; Sun Y; Dai LP; Yan CB; Xiong W; Cui QH; Yu HJ; Yu M; Qin Y
    Biochem Biophys Res Commun; 2018 Sep; 503(2):888-894. PubMed ID: 29928884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.
    Mikkilineni L; Whitaker-Menezes D; Domingo-Vidal M; Sprandio J; Avena P; Cotzia P; Dulau-Florea A; Gong J; Uppal G; Zhan T; Leiby B; Lin Z; Pro B; Sotgia F; Lisanti MP; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):218-225. PubMed ID: 29248133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.
    Diehl K; Dinges LA; Helm O; Ammar N; Plundrich D; Arlt A; Röcken C; Sebens S; Schäfer H
    Oncogene; 2018 Jan; 37(1):39-51. PubMed ID: 28846107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.
    Martinez-Outschoorn UE; Curry JM; Ko YH; Lin Z; Tuluc M; Cognetti D; Birbe RC; Pribitkin E; Bombonati A; Pestell RG; Howell A; Sotgia F; Lisanti MP
    Cell Cycle; 2013 Aug; 12(16):2580-97. PubMed ID: 23860378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.
    Witkiewicz AK; Whitaker-Menezes D; Dasgupta A; Philp NJ; Lin Z; Gandara R; Sneddon S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Mar; 11(6):1108-17. PubMed ID: 22313602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.
    Fiaschi T; Marini A; Giannoni E; Taddei ML; Gandellini P; De Donatis A; Lanciotti M; Serni S; Cirri P; Chiarugi P
    Cancer Res; 2012 Oct; 72(19):5130-40. PubMed ID: 22850421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
    Ko YH; Domingo-Vidal M; Roche M; Lin Z; Whitaker-Menezes D; Seifert E; Capparelli C; Tuluc M; Birbe RC; Tassone P; Curry JM; Navarro-Sabaté À; Manzano A; Bartrons R; Caro J; Martinez-Outschoorn U
    J Biol Chem; 2016 Dec; 291(51):26291-26303. PubMed ID: 27803158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.
    Whitaker-Menezes D; Martinez-Outschoorn UE; Lin Z; Ertel A; Flomenberg N; Witkiewicz AK; Birbe RC; Howell A; Pavlides S; Gandara R; Pestell RG; Sotgia F; Philp NJ; Lisanti MP
    Cell Cycle; 2011 Jun; 10(11):1772-83. PubMed ID: 21558814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth.
    Guido C; Whitaker-Menezes D; Lin Z; Pestell RG; Howell A; Zimmers TA; Casimiro MC; Aquila S; Ando' S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2012 Aug; 3(8):798-810. PubMed ID: 22878233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.
    Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A
    BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma.
    Gooptu M; Whitaker-Menezes D; Sprandio J; Domingo-Vidal M; Lin Z; Uppal G; Gong J; Fratamico R; Leiby B; Dulau-Florea A; Caro J; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):204-217. PubMed ID: 29248132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells.
    De Saedeleer CJ; Copetti T; Porporato PE; Verrax J; Feron O; Sonveaux P
    PLoS One; 2012; 7(10):e46571. PubMed ID: 23082126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes.
    Pérez de Heredia F; Wood IS; Trayhurn P
    Pflugers Arch; 2010 Feb; 459(3):509-18. PubMed ID: 19876643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
    Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
    Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The redox switch/redox coupling hypothesis.
    Cerdán S; Rodrigues TB; Sierra A; Benito M; Fonseca LL; Fonseca CP; García-Martín ML
    Neurochem Int; 2006; 48(6-7):523-30. PubMed ID: 16530294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocarboxylate transporters in the brain and in cancer.
    Pérez-Escuredo J; Van Hée VF; Sboarina M; Falces J; Payen VL; Pellerin L; Sonveaux P
    Biochim Biophys Acta; 2016 Oct; 1863(10):2481-97. PubMed ID: 26993058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.